Position in FTRE
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$265,715
+$121,863 QoQ
Shares Held
15,271
0.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#165
of 330 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cohen Klingenstein LLC holds $3,246,095 across 2 Biotechnology names. FTRE ranks #2 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,000 | $2,980,380 | |
| 2 | FTRE |
Fortrea Holdings Inc.
This page
|
15,271 | $265,715 |
All Filings in FTRE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $265,715 | 15,271 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $143,852 | 15,271 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $263,424 | 15,271 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $128,581 | 15,271 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $75,438 | 15,271 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $124,356 | 16,471 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $415,354 | 22,271 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $475,420 | 23,771 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $565,388 | 24,224 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,032,842 | 25,731 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $947,639 | 27,153 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $776,304 | 27,153 | Shares | Sole | 2023-10-13 | |
| No filing history on record for this holder in this stock. | ||||||